Key Market Indicators
Sales of analgesic medicines in Canada are expected to reach $681 million by 2026, down from $786 million in 2021. That's an average year-on-year decrease of 1.8%. Since 2017, the Canadian market has seen an average annual decline of 1.4%. In 2021, Canada was ranked third among countries with the highest analgesic sales, behind Spain and Italy. Spain held the top spot with $786 million, followed by Canada at $786 million and Italy at $786 million.
